{"id":"cellular-matrix-a-cp-ha-kit","safety":{"commonSideEffects":[]},"_chembl":{"chemblId":"CHEMBL4303619","moleculeType":"Small molecule","molecularWeight":"489.48"},"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"The A-CP-HA Kit is a regenerative medicine product that uses autologous cellular components (likely adipose-derived or bone marrow-derived cells) combined with hyaluronic acid as a scaffold matrix. This combination aims to facilitate tissue repair, reduce inflammation, and promote healing through cell-based and biomaterial-mediated mechanisms in damaged or degenerative tissues.","oneSentence":"A cellular matrix product combining autologous cells with hyaluronic acid to promote tissue regeneration and repair.","_ai_confidence":"low"},"_scrapedAt":"2026-03-28T00:29:52.308Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Tissue regeneration and repair (specific indications not publicly detailed)"}]},"trialDetails":[{"nctId":"NCT06425978","phase":"PHASE4","title":"Efficacy of the Use of Cellular Matrix/ A-CP-HA Kit","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2024-05-30","conditions":"Genitourinary Syndrome of Menopause","enrollment":192},{"nctId":"NCT03211650","phase":"PHASE4","title":"Efficacy of Hyaluronic Acid and Platelet-rich Plasma Combination in Knee Osteoarthritis","status":"COMPLETED","sponsor":"University of Milan","startDate":"2016-10-14","conditions":"Knee Osteoarthritis","enrollment":174},{"nctId":"NCT02964143","phase":"NA","title":"Clinical Investigation to Compare the Safety and Efficacy of Cellular Matrix to Those of Ostenil® Plus and to Those of PRP Only","status":"UNKNOWN","sponsor":"Regen Lab SA","startDate":"2020-06-01","conditions":"Knee Osteoarthritis","enrollment":306},{"nctId":"NCT03328728","phase":"NA","title":"Cellular Matrix Device for the Treatment of Mild to Moderate Knee Osteoarthritis","status":"UNKNOWN","sponsor":"Regen Lab SA","startDate":"2017-07-18","conditions":"Knee Osteoarthritis","enrollment":190}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":628,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Cellular Matrix / A-CP-HA Kit","genericName":"Cellular Matrix / A-CP-HA Kit","companyName":"Fundación Santiago Dexeus Font","companyId":"fundaci-n-santiago-dexeus-font","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A cellular matrix product combining autologous cells with hyaluronic acid to promote tissue regeneration and repair. Used for Tissue regeneration and repair (specific indications not publicly detailed).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":false,"trials":true,"score":3}}